Utah Medical Products, Inc. (FRA:UTM)

Utah Medical Products Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	154	201	277	341	321	251
Market Cap Growth	-25.56%	-27.18%	-18.96%	6.29%	27.96%	-29.88%
Enterprise Value	82	116	197	277	265	213
Last Close Price	46.80	56.59	74.90	-	-	-
PE Ratio	15.57	15.03	18.38	22.14	24.69	28.42
PS Ratio	4.68	5.10	6.09	6.98	7.44	7.28
PB Ratio	1.53	1.78	2.38	3.19	3.41	2.99
P/TBV Ratio	1.76	2.07	2.79	4.03	4.85	4.75
P/FCF Ratio	13.04	14.28	14.12	17.93	17.68	15.92
P/OCF Ratio	12.79	14.06	13.72	17.25	17.22	15.24
EV/Sales Ratio	2.47	2.94	4.34	5.65	6.14	6.19
EV/EBITDA Ratio	5.89	6.49	8.80	11.02	11.51	12.50
EV/EBIT Ratio	7.23	7.65	11.81	14.93	15.95	19.04
EV/FCF Ratio	6.93	8.24	10.06	14.53	14.58	13.54
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.02	0.01	0.01	0.02	0.02
Debt / FCF Ratio	0.02	0.02	0.01	0.02	0.02	0.02
Asset Turnover	0.31	0.32	0.39	0.44	0.43	0.38
Inventory Turnover	1.92	1.82	2.19	2.61	2.83	2.53
Quick Ratio	29.22	23.18	20.44	13.52	17.65	14.69
Current Ratio	32.06	25.64	22.56	15.09	19.54	16.42
Return on Equity (ROE)	9.59%	11.29%	13.72%	14.88%	14.09%	10.59%
Return on Assets (ROA)	6.56%	7.62%	8.89%	10.33%	10.38%	7.74%
Return on Capital (ROIC)	6.79%	7.98%	9.48%	11.14%	11.20%	8.37%
Return on Capital Employed (ROCE)	11.10%	13.20%	14.10%	16.80%	16.90%	12.70%
Earnings Yield	6.42%	6.65%	5.44%	4.52%	4.05%	3.52%
FCF Yield	7.67%	7.00%	7.08%	5.58%	5.66%	6.28%
Dividend Yield	2.37%	2.06%	1.43%	-	-	-
Payout Ratio	34.80%	30.70%	25.74%	19.20%	77.53%	38.12%
Buyback Yield / Dilution	7.79%	3.68%	0.16%	0.46%	0.33%	1.79%
Total Shareholder Return	10.16%	5.74%	1.59%	0.46%	0.33%	1.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.